Leflunomide as adjuvant treatment of dermatomyositis

Journal of the American Academy of Dermatology
J Scott Boswell, Melissa I Costner

Abstract

We report 3 cases of recalcitrant dermatomyositis that responded to the addition of daily leflunomide, a novel immunomodulatory drug that is currently used to treat rheumatoid arthritis. In our patients, leflunomide proved both safe and effective as adjuvant therapy in treating dermatomyositis.

References

Oct 13, 2000·Archives of Dermatology·H C Nousari, G J Anhalt
Oct 29, 2000·Annals of the Rheumatic Diseases·F C Breedveld, J M Dayer
Nov 10, 2001·Dermatology : International Journal for Clinical and Investigative Dermatology·E A HolmG B Jemec
Jun 21, 2002·Clinical Pharmacokinetics·Blaz Rozman
Aug 3, 2002·Rheumatology·M T Carulli, U M Davies
Aug 15, 2002·Annals of the Rheumatic Diseases·F SoliotisA S M Jawad
Dec 5, 2002·Clinical and Experimental Dermatology·U Frieling, T A Luger
Apr 24, 2003·Rheumatology·V MajithiaJ G Wilson
Sep 27, 2003·Lancet·Marinos C Dalakas, Reinhard Hohlfeld
Dec 6, 2003·Dermatology : International Journal for Clinical and Investigative Dermatology·Tobias W FischerPeter Elsner
Apr 6, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Eric N van RoonJacobus R B J Brouwers
Apr 30, 2004·Clinical and Experimental Dermatology·O A KerrM J Tidman
May 20, 2004·The British Journal of Dermatology·J A Tlacuilo-ParraM Salazar-Páramo
May 25, 2004·Expert Opinion on Pharmacotherapy·Richard D Sontheimer
Jun 5, 2004·Clinical Pharmacology and Therapeutics·Renan A Bonnel, David J Graham
Jun 10, 2004·The Annals of Pharmacotherapy·Jonathan ChanPeter I Pillans
Jun 24, 2004·Rheumatology·A Bharadwaj, Nigil Haroon
Jun 25, 2004·The British Journal of Dermatology·J SchmittC Pfeiffer
Dec 21, 2004·Annals of the Rheumatic Diseases·D GensburgerP Miossec
Mar 11, 2005·Rheumatology·V GoëbX Le Loët

❮ Previous
Next ❯

Citations

Jun 12, 2013·American Journal of Clinical Dermatology·Alisa N FemiaJeffrey P Callen
Mar 27, 2009·Rheumatology·Batsi ChikuraJulie K Dawson
Sep 20, 2011·Current Opinion in Rheumatology·Heřman F Mann, Jiří Vencovský
Jul 16, 2008·Current Opinion in Pediatrics·David G Gamboa, Jeffrey L Sugarman
Jul 16, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Anne TournadreMartin Soubrier
Jul 9, 2008·Current Allergy and Asthma Reports·Jeffrey P Callen
Oct 4, 2011·Journal of the American Academy of Dermatology·Alan S Boyd
Jun 30, 2012·Dermatologic Therapy·Christina Lam, Ruth Ann Vleugels
Aug 2, 2011·The Journal of Dermatological Treatment·Virendra N Sehgal, Prashant Verma
Feb 22, 2011·La Presse médicale·Isabelle Marie
Nov 22, 2017·The Journal of Dermatological Treatment·Verena Isak, Joseph L Jorizzo
Feb 26, 2020·American Journal of Clinical Dermatology·Gabriela A CobosRuth Ann Vleugels
Jun 28, 2019·Clinical Medicine Insights. Case Reports·John Okogbaa, Lakeasha Batiste
Nov 16, 2021·Expert Opinion on Investigational Drugs·Rachel ZengJens Schmidt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.